This doesn't sound like a partnership is imminent. I was holding my breath that there might be a Friday night filing, but it didn't happen. King needs to do a deal for something, not just continuing to dilute us into oblivion.
I sure hope its not for anything to do with the ATM.
My extreme hopium addiction may be influencing my reaction but here is why I think its not for ATM:
1) IF for ATM just to raise money.... why the trip to NY and Boston on top of the conferences lined up in March (Cowen and Roth)and I would think if they need to raise money... it can easily be done from the office over the phone
2) Key clients (one or more or VC group) are interested but want to hear first hand the entire story from Peregrine in person.
NOTE: Whether BP talks are going well.... agreeing on terms or not... I think Peregrine will keep moving along in getting interest back in their corner. BP's may see this momentum swing and like the 4 year old who sees someone else holding something (shares)... it gets that BP "more" motivated to get a deal done on Peregrines terms.
To me it seems more like they are laying out their version to the ... big money clients.... and will give their future outlook... and offer hints on the news to come and give them the opportunity to invest in Peregrine now at these prices. This help raise the Institutional Ownership... and at the same time puts pressure on the partnering talks.... one will give in first and either one is going to help the stock price.
Peregrine is not going to NY and Boston on a bluff and nothing to show for it.... clients want to see their cards on the table
Peregrine is not going to go to a medical conference on a bluff... medical community will see all the cards on the table
As for the BP's.... I forgot who said it, but liked the part where it was mentioned that the partner will have their scientist maybe in one meeting .. if one... to verify this science is validated by data..etc and they will shuffle them back to the labs to hide the grins and smiles from their faces! ....as the lawyers M/A team walk back in for negotiations and try to low ball Peregrine in every way.
Peregrine can only make a partnering deal once and they don't want to be sitting at this years ASM regretting anything.
I agree. The investor meetings would be no secret within the investment community and there could be sales/shorting of the stock knowing yet another major dilution is coming. That would explain the downward pressure on the stock. I hope not, but it does seem likely with this crew who never met an ATM they didn't like and always seems to pick a low pps to execute it. We've had alot of dilution this last year and no reason to believe it will stop anytime soon. Too bad Lytle didn't fill the coffers when the pps was at $3+ last August.
Market Data 
Markets 
AI
